| |
| |
|
| Insider
Information: |
Khattar Jack A. |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,378,841 |
|
|
Indirect Shares
|
2,118,700 |
|
|
| Direct
Value |
$23,786,490 |
|
|
|
Indirect Value
|
$26,573,476 |
|
|
| Total
Shares |
3,497,541 |
|
|
| Total
Value |
$50,359,965 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -42.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Supernus Pharmaceuticals Inc |
SUPN |
President, CEO, Director |
2024-02-28 |
915,217 |
2024-02-28 |
1,022,450 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
President, CEO, Director |
2016-03-29 |
444,124 |
2016-03-29 |
1,096,250 |
Premium* |
|
|
Scpharmaceuticals Inc. |
SCPH |
Director |
2021-12-03 |
5,000 |
2021-12-03 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2019-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
457,565 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2019-12-26 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,100 |
4,000 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2019-12-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,300 |
461,841 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2020-03-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(13,000) |
1,068,450 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2020-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
475,216 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2020-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
506,466 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
516,466 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2021-03-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
1,058,450 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2021-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
556,466 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-03-14 |
4/A |
OE |
$0.00 |
$0 |
D/D |
40,000 |
556,466 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-03-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
20,000 |
576,466 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
616,466 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-03-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,750) |
1,047,700 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-03-18 |
4 |
A |
$0.00 |
$0 |
D/D |
10,750 |
627,216 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
192,000 |
819,216 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
63,100 |
764,409 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,900 |
769,878 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,575 |
788,016 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,530 |
799,431 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,895 |
781,454 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2022-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
807,581 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
813,022 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-02-15 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,750) |
1,038,950 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,000 |
833,022 |
0 |
- |
|
| SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
• • – |
2023-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
864,272 |
0 |
- |
|
99 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
